The E2-induced fibrotic pathways and ECM deposition observed in our study align with observations in various other TGF-β–driven conditions such as dermal fibrosis, systemic sclerosis, benign prostatic hyperplasia, and hepatic fibrosis, underscoring the potential widespread relevance of our findings (45–49). The gene discussed is TGFB1; the disease is systemic sclerosis.